Allogene Therapeutics
Yuan Lin is a Principal Scientist at Allogene Therapeutics since June 2022, with previous experience as a Senior Scientist at Bristol Myers Squibb and a Staff Scientist at Thermo Fisher Scientific. Yuan has significant expertise in the development and analysis of single-cell gene expression profiling related to drug resistance in breast cancer, as well as the characterization of tumor-initiating cells in various models. Prior roles include postdoctoral positions at BioVision and Stanford University, where Yuan focused on gene transfer in hematopoietic stem cells and conducted research on tumor biology. Yuan's academic background includes a PhD in Molecular Virology from Case Western Reserve University, complemented by a Master's degree in Traditional Chinese Medicine and a Bachelor's degree in Biology. Early career experience includes roles at Clontech involving DNA microarray production and quality control.